L059

· UCB Japan Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for L059, covering 2013-03-07 to 2013-03-07. Get the full timeline:

Most recent: Clinical Trial Update: An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures [Phase 2]